70860-402 : Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution


NDC70860-402
Labeler: Athenex Pharmaceutical Division, LLC.
Product Type: Human Prescription Drug
Drug Name:  Bivalirudin
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA210031
Rev. Date: 


NDC Package Codes:

  • 70860-402-10: 10 VIAL, SINGLE‑DOSE IN 1 CARTON (70860‑402‑10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑DOSE (70860‑402‑41)

Active Ingredients:

  • Bivalirudin

Dosage Strength:

  • 250 mg

Pharmaceutical Classes:

  • Anti-coagulant [EPC]
  • Direct Thrombin Inhibitor [EPC]
  • Thrombin Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0409-8300 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0781-3158 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz
  • 0781-9158 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz
  • 16729-275 Bivalirudin 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare, Inc.
  • 25021-405 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 52958-034 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
  • 55111-652 Bivalirudin 250 mg Intracavernous Injection by Dr. Reddy's Laboratories Limited
  • 55150-210 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Auromedics Pharma LLC
  • 60505-6101 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
  • 63323-562 Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 67457-256 Bivalirudin 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 69097-601 Bivalirudin 250 mg Intravenous Injection by Cipla USA Inc.
  • 70511-141 Bivalirudin 250 mg Intravenous Injection, Solution by Maia Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70860-402 QR Code

< Prev: 70860-400Next: 70860-403 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 8 February 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA